A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)
PHASE1
This open-label Phase I study is designed to determine the maximum tolerate...
Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial
N/A
The ALLIVE (ALLogeneic Iron inVEstigators) trial aims at quantifying the ex...
Status
Completed
Location
III. Medizinischen Klinik Hämatologie und Internistische Onkologie Universitätsmedizin Mannheim